Cargando…
OR29-01 Deleting Salt Inducible Kinases In Osteoprogenitor Cells Increases Trabecular Bone
Disclosure: G. Papaioannou: None. A. Morellato Alcantara: None. K. Strauss: None. H.M. Kronenberg: None. M.N. Wein: Other; Self; Radius Health, Inc, research funding and patent royalties, holds equity in and is a scientific advisory board member of Relation Therapeutics, consultant for AstraZeneca,...
Autores principales: | Papaioannou, Garyfallia, Morellato Alcantara, Ana Clara, Strauss, Katelyn, Kronenberg, Henry M, Nathan Wein, Marc |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554091/ http://dx.doi.org/10.1210/jendso/bvad114.566 |
Ejemplares similares
-
THU415 Trabecular Bone Score In Hospitalized Patients With Heart Failure
por: Bandeira, Francisco, et al.
Publicado: (2023) -
THU417 Associations Between Glucose Metabolism And Trabecular Bone Score In Subjects With Acromegaly
por: Kuzma, Martin, et al.
Publicado: (2023) -
OR29-01 Long-Term Safety in Adults with X-Linked Hypophosphatemia (XLH) Treated with Burosumab, a Fully Human Monoclonal Antibody Against FGF23: Final Results of a Phase 3 Trial
por: Perwad, Farzana, et al.
Publicado: (2020) -
SAT-405 Trabecular Bone Score (TBS) in Primary Hyperparathyroidism (PHP): A Useful Tool?
por: Santos, Lívia Marcela, et al.
Publicado: (2020) -
SUN-368 Wnt Inhibition Decreases Trabecular Bone in a Mouse Model of Fibrous Dysplasia
por: Lung, Hsuan, et al.
Publicado: (2020)